Followers | 17 |
Posts | 936 |
Boards Moderated | 0 |
Alias Born | 04/26/2010 |
Monday, June 11, 2018 8:24:39 AM
You may not remember that this was discussed before: prurisol 2b trial enrollment got very back heavy. Original primary end date for the trial was June 2017, but enrollment reached only 70 % by mid-May 2017.
Heavy backend enrollment also meant delays on gathering and processing trial data. I would not be surprised if IPIX started to put pressure on CRO by Q3 2017. That may have backfired and created a mess --> CRO adds workforce on prurisol trial --> additional workforce may have been inexperienced with the type of trial --> something got omitted or mishandled --> reset data processing.
Of course this is just my opinion, but it is based on reading about problems associated with CRO:s. Most complaints are about what happens when CRO:s do reduce cost by
1. Assigning less educated plus less experienced and hence a lot cheaper persons to do tasks they are not yet qualified.
2. Compressing time allotted to process and verify data.
Disasters happen with the above recipe. BTW, big money pharma tends to keep crucial trials in house and hand "Mee-Too" stuff to CRO's. You should be now able to guess why.
If I am correct it does not necessarily follow that CRO just re-processes the data and delivers it badly late but in good condition. It all depends on at which stage of data collection the errors were made - there may or may not be a permanent data loss.
Remember to bless FDA in your evening prayers. If my memory serves me, FDA still requires that all site trial data is preserved (locally) for some years after the trial - there is hope.
"There's no sense in being precise when you don't even know what you're talking about." John v. Neumann
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM